Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07472062

Development of a Non-Invasive Prognostic Test for Graves Orbitopathy

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this research project is to develop a non-invasive, simple, robust, and sensitive prognostic test that can identify hyperthyroidism patients who are at risk of developing Graves' Orbitopathy. This phase of the study is a research phase in which we analyze blood samples and tear fluid using standard laboratory equipment and software. The aim is to identify biomarkers that can detect patients at risk of developing Graves' Orbitopathy. Offering more personalized advice, treatment, and follow-up could potentially prevent the clinical consequences or limit their severity.

Conditions

Interventions

TypeNameDescription
OTHERSchirmer's testCollection of tears with Schirmer's test

Timeline

Start date
2023-05-13
Primary completion
2024-06-25
Completion
2026-12-31
First posted
2026-03-16
Last updated
2026-03-16

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT07472062. Inclusion in this directory is not an endorsement.

Development of a Non-Invasive Prognostic Test for Graves Orbitopathy (NCT07472062) · Clinical Trials Directory